Results 121 to 130 of about 108,288 (261)
ABSTRACT Background Peptic ulcer disease (PUD) continues to be a health issue, mainly due to Helicobacter pylori (H. pylori) infection and non‐steroidal anti‐inflammatory drugs (NSAIDs). Despite better treatment of H. pylori and use of proton pump inhibitors, the rate of reduction in PUD complications is slowing down.
Vidya Willis +3 more
wiley +1 more source
Primary Diffuse large B-cell lymphoma of spleen: A rare case report
Primary splenic lymphoma is very rare with an incidence less than 1% and, 22% to 33% of the cases being diffuse large B-cell lymphoma with a relatively favourable prognosis.
Biswajit Dey +5 more
doaj
Summary Diffuse large B‐cell lymphoma (DLBCL) is the most common aggressive non‐Hodgkin lymphoma and is characterized by substantial heterogeneity. This study aimed to develop a liquid–liquid phase separation (LLPS)‐related prognostic model to improve risk stratification.
Zhen‐Zhong Zhou +11 more
wiley +1 more source
Primary Diffuse Large Cell Lymphoma of the Bladder: Case Report and Literature Review
Most bladder tumors are epithelial in origin. Nonepithelial cancers are rarely located in the bladder. Sarcomas are the most common malignancies among nonepithelial cancers. Primary bladder lymphoma is rare and mostly low grade. Here, we have reported
Mansour Ansari +8 more
doaj
Summary Early identification of patients at risk of failing first‐line therapy remains a key challenge in primary mediastinal B‐cell lymphoma (PMBCL). This study assessed whether positron emission tomography (PET) radiomics could predict treatment outcomes in PMBCL.
L. Ceriani +10 more
wiley +1 more source
Diffuse Large B-Cell Lymphoma Presenting With Superior Vena Cava Syndrome and Recurrent Pleural Effusions in a Patient With Angelman Syndrome: A Case Report. [PDF]
Khalid A +5 more
europepmc +1 more source
Diffuse Large B-cell Lymphoma of the Testis [PDF]
Rosalind F, Sandell, Lori A, Erickson
openaire +2 more sources
Summary Response assessment in diffuse large B‐cell lymphoma (DLBCL) has traditionally relied on anatomical and metabolic imaging, with fluorodeoxyglucose positron emission tomography (FDG‐PET)–defined complete metabolic remission representing the principal end‐point of first‐line therapy. However, growing evidence indicates that metabolic control does
Santino Caserta +12 more
wiley +1 more source
Spinal Cord Compression due to Pyothorax-Associated Lymphoma: A Rare Presentation of EBV-Positive Diffuse Large B-Cell Lymphoma. [PDF]
Yanagisawa K +4 more
europepmc +1 more source

